Gene Query: ZFP41

Dataset Description Geneva Score
The stress granule transcriptome reveals principles of mRNA accumulation in stress granules. 16.69
RNA-sequencing time course of Human Intestinal Epithelial Cells (HIECs) following knockdown of miR-30bcd using complementary locked nucleic acids 14.05
POLR3G Dependent PolyA+ and smallRNA Transcriptomes in Human Pluripotent Stem Cells 11.42
RNA-seq analysis of control and ZC3H18-depleted ovarian cancer cells 10.16
Interaction with WDR5 recruits MYC to a small cohort of genes required for tumor onset and maintenance 10.13
Next Generation Sequencing and m6A sequencing Facilitates Quantitative Analysis of Wild Type and genetic FTO knockdown ccRCC cells Transcriptomes 8.67
Transcriptional Modulation of Human Endogenous Retroviruses in Primary CD4+ T Cells Following Vorinostat Treatment 6.64
Effect of REST on cancer invasiveness in MCF-7 and MDA-MB-231 cells using RNA-sequencing (RNA-seq) analysis . 6.5
m6A-seq data analysis of control and PCIF1 knockdown transcriptome 6.21
RRAD, IL4I1, CDKN1A, and SERPINE1 genes are potentially co-regulated by NF-κB and p53 transcription factors in cells exposed to high doses of ionizing radiation [RNA-Seq] 6.17
Genetic disruption of COX-1 inhibits multiple oncogenic pathways 6.12
A high-throughput screening strategy identifies regulators of alternative splicing via interaction with RNA G-quadruplexes 5.9
Heterogeneous nuclear ribonucleoprotein C1/C2 links transcriptional and splicing actions of 1,25-dihydroxyvitamin D 5.35
Bladder-cancer-associated mutations in RXRA activate peroxisome proliferator-activated receptors to drive urothelial proliferation 4.97
Bladder cancer associated mutations in RXRA activate peroxisome proliferator-activated receptors 4.97
Mutational landscape of splicing genes and functional consequences across 33 cancer types 4.69
SIRT7 Antagonizes TGF-β Signaling and Inhibits Breast Cancer Metastasis 4.59
The effect of engineered del(7q) on induced pluripotent stem cells (iPSCs) derived from patients with Shwachman Diamond Syndrome (SDS). 4.34
CRISPR activation of long non-coding RNAs transiently expressed during cortical neuron differentiation associated with Field, et al, Stem Cell Reports 2018 4.21
HeLa transcriptome induction by IFN gamma and indoleamine 2,3-dioxygenase (IDO) 4.14
RNA-seq of HDAC2-disrupted 293FT cells by CRISPR-Cas9 4.13
Differential roles of human PUS10 in miRNA processing and tRNA pseudouridylation 4.11
Transcriptome variation among human embryonic stem cell lines impacts on their differentiation 4.1
The effect of spontaneous acquisition of an extra chromosome 7 for engineered del(7q) on induced pluripotent stem cells (iPSCs) derived from patients with Shwachman Diamond Syndrome (SDS). 4.02
Sequencing of messenger RNAs with N6-methyladenosine modifications in acute myeloid leukemia (AML) with and without forced expression of FTO 3.85
Identification of the O-GlcNAc-regulated alternative splicing events by performing RNA sequencing on HeLa cells with altered O-GlcNAc level. 3.84
DART-seq: an antibody-free method for global m6A detection 3.82
Tristetraprolin disables prostate cancer maintenance by impairing proliferation and metabolic function 3.76
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer (RNA-seq) 3.56
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer 3.56
The SPOP-containing Complex Functions as an E3 Ligase for SETD2 to Regulate Gene-Specific H3K36me3-Coupled Alternative Splicing 3.55
Transcriptomic but not genomic variability confers phenotype of breast cancer stem cells 3.46
Next Generation Sequencing of control (Untreated), PAN injured and Adriamycin injured human podocytes 3.42
Differetially expressed genes after hTR overexpression in U2OS cells 3.36
UV-Irradiation Induces a Noncoding RNA that Functionally Opposes the Protein Encoded by the Same Gene 3.33
RNA-sequencing WT vs SOCS3 knockout Glioblastoma stem-cells 3.31
RNA-seq analysis of control and CDK12-depleted ovarian cancer cells 3.15
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [ESRP KD] 3.15
Identification of PRMT5-dependent genes in ESA+CD24lowCD44+ MCF7 cells 3.08
Gene expression profiling via RNA sequencing of patient brain tumors cultured in 3D bioengineered cultures 3.02
The Jumonji-domain histone demethylase inhibitor JIB-04 deregulates oncogenic programs and increases DNA damage in Ewing Sarcoma, resulting in impaired cell proliferation and survival, and reduced tumor growth 2.96
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [K562] 2.95
RNA-seq of naive and primed ES cells (NHSM) 2.92
Induced pluripotent stem cell modeling of bone marrow failure and MDS identifies therapeutic targets 2.85
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability 2.75
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability [RNA-Seq] 2.75
Quantitative Analysis of negative control and overexpression-TRIB1 in PC3 and DU145 Transcriptomes 2.74
Spatially Constrained Tandem Bromodomain Inhibition Bolsters Sustained Repression of BRD4 Transcriptional Activity for TNBC Cell Growth 2.71
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [cPDS-RNA-seq] 2.68
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_RNA-seq] 2.64
Understanding the Mechanistic Contribution of Herbal Extracts in Compound Kushen Injection with Transcriptome Analysis 2.64
RNA m5C Methylation in breast cancer using MeRIP-Seq 2.61
Genome-wide maps in MCF-7 cells with six2 or CYP4Z1 3'UTR or CYP4Z2P 3'UTR overexpression or not 2.6
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-seq of KLF6 KO) 2.57
Transcriptome analysis of ECFCs treated with GSK-343 and Panobinostat 2.52
Global epigenomic reconfiguration during mammalian brain development 2.51
A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters 2.49
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_sgrna] 2.45
Chromatin-informed inference of transcriptional programs in gynecologic cancers [RNA-Seq] 2.43
Chromatin-informed inference of transcriptional programs in gynecologic cancers 2.43
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung 2.36
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung [RNA-seq] 2.36
Silencing SPIB in attached and floating state of H1703 lung cancer cells 2.31
Global Regulation of Alternative Internal Exon Usage by mRNA 3' End Formation Factors [RNA-Seq] 2.31
Global Promotion of Alternative Internal Exon Usage by mRNA 3' End Formation Factors 2.31
A role for ZNF598 in post-transcriptional gene regulation 2.29
RNA sequencing of lncRNAs knockdown in human pancreatic cancer cell lines 2.28
RNA-seq analysis to identify the genes regulated by p53-SET interplay 2.27
Integrated analyses of early responses to radiation in glioblastoma identify new alterations in RNA processing and candidate targets to improve treatment outcomes 2.25
Analysis of transcriptome changes following SOX2 knockdown in three different Ewing sarcoma cell lines 2.25
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [MB157_RNA-seq] 2.25
Epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 2.24
Gene expression profiling study by RNA-seq for identifying genes associated with epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 2.24
A global identification of PUM1 and PUM2 mRNA targets and their protein cofactors in human seminoma TCam-2 cells 2.24
RNASeq of MV4;11 cells transduced with scramble shRNA or BRD4 shRNA in combination with DMSO or SGC0946 2.2
Multiple mechanisms disrupt let-7 miRNA biogenesis and function in neuroblastoma [longRNA] 2.2
Silencing p300 in MCF7 cells to study expression and alternative splicing 2.17
RNAseq of Extracellular vesicle RNAs and cellular RNAs from HPASMCs with or without TGF-b1 or BMP4 treatment 2.17
Coordination of neuron production in mouse and human cerebral cortex by the homolog of Drosophila Mastermind protein 2.14
Overexpression and knockdown experiment for circCSNK1G3 2.13
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression 2.11
Major hnRNP proteins act as general TDP-43 functional modifiers both in Drosophila and human neuronal cells. 2.11
The evolution of N6-methyladenosine in primates 2.11
Exploring ILF2 regulatory genes by next-generation sequencing 2.1
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders [lnc-Nr2f1 overexpression] 2.08
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders 2.08
TGFβ-induced fibroblast activation requires persistent and targeted HDAC-mediated gene repression 2.06
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export II 2.06
A combinatorial screen of the CLOUD uncovers a synergy targeting the androgen receptor 2.03
Messenger RNA profile analysis deciphers new Esrrb responsive genes in prostate cancer cells 2.01
NR2F2 study 1.99
Estrogen response in breast cancer cell line MCF-7 is dependent on NR2F2 [RNA-seq] 1.99
LED, a long non-coding RNA activator of enhancer RNAs, is hypermethylated in human cancers 1.99
Characterization of macrophage - cancer cell crosstalk in estrogen receptor positive and triple-negative breast cancer 1.95
A Brain Penetrant Mutant IDH1 Inhibitor Provides In Vivo Survival Benefit 1.95
Small-molecule targeting of brachyury transcription factor addiction in chordoma 1.94
Next Generation Sequencing Analysis of Colorectal Cancer Tissue Transcriptomes 1.91
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and AXL-/- astrocytes Transcriptomes 1.88
RNA-seq data corresponding to: AZD4573 is a highly selective CDK9 inhibitor that suppresses Mcl-1 and induces apoptosis in hematological cancer cells 1.88
Next Generation Sequencing Quantitative Analysis of Wild Type and AML1-ETO Related Fusion Circular RNA (F-CircAE) Knockdown Kasumi-1 Cells Transcriptomes 1.88
Modulation of SF3B1 causes global intron retention and downregulation of the B-cell receptor pathway in chronic lymphocytic leukemia 1.83
RNA transcriptome analysis of IRF1 and IRF3 knockout in immortalized primary hepatocytes infected with hepatitis A virus 1.82
MYCi975 regulates MYC target genes 1.82
Comparison between THP-1 cells obtained from either ATCC or DSMZ biorepository 1.81
Effect of circPTPRM on the biological behaviors of hepatocellular carcinoma cells in vitro and its clinical significance. 1.8
Effect of estrogen (E2) treatment on the C4-12 relative to the MCF7 cells 1.8
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques 1.8
Effect on small molecule RBPJ inhibitor (RIN1) on gene expression in Jurkat cells compared to gamma secretase inhibition and siRNA knockdown of RBPJ 1.78
CHD1 regulates cell fate determination by activation of differentiation-induced genes 1.77
Identification of global regulators of T-helper cell lineage specification 1.75
Identification of global regulators of T-helper cell lineage specification (RNA-Seq) 1.75
Analysis of active enhancers and direct androgen receptor target genes in VCaP prostate cancer cells 1.75
RNA sequencing for lncRNA, miRNA and mRNA expression analysis in human laryngeal cancer 1.74
A role for p53 in the adaptation to glutamine starvation through the expression of Slc1a3 1.73
Transcriptional profile of CAOV2 ovarian cancer cells with TAZ silencing 1.73
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice 1.73
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice [RNA-seq] 1.73
Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13 1.73
Transcriptional response to the HSP70 inhibitor MAL3-101 in parental rhabdomyosarcoma cells and isogenic acquired-resistance lines. 1.7
Splicing and gene expression changes in human MDAM-MB231 breast cancer cells with TRA2B knockdown 1.68
U1 snRNP telescripting regulates size-function stratified human genome 1.67
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1 and H1 after SNAI1 deletion at Day2 after human early hematopoietic differentiation . 1.66
Studying the selectivity of a small molecule Synucleozid on transcriptome 1.66
Identifying ASCL1 target genes in primary GBM stem cell cultures [RNA-seq] 1.65
Dynamics of the human and viral m6A RNA methylomes during HIV-1 infection of T cells 1.65
RNA-seq in SUNE-1 cells after downregulation of DANCR expression 1.63
Transcriptional profiling of MCF7 cells treated with H3B05942, E2, or standard of care compounds 1.62
RNA-sequencing of bulk CD19+ Thymic B cells from young (3 month - 4 year) and old (42 - 61 years) humans 1.61
RNA-sequencing of bulk CD19+ Thymic B cells from mice and humans 1.61
Effects of NSUN2 deficiency on the mRNA 5-methylcytosine modification and gene expression profile in HEK293 cells (RNA-Seq) 1.61
Profiling of circular RNAs in gastric cancer tissues and adjacent normal tissues 1.6
Global Mapping of Human RNA-RNA Interactions 1.6
The effect of REST and its alternatively spliced transcript, REST-003, on breast cancer invasiveness 1.57
Transcriptome analysis of SH-SY5Y cells after knockdown of circSLC45A4 1.56
ERK signaling regulates opposing functions of JUN family transcription factors in prostate cancer cell migration 1.56
Differential gene expression by suppression of either SOX2 or TP63 in KYSE70 human esophageal squamous carcinoma cell line. 1.55
Acquired resistance to MEK-CDK4/6 inhibitor combinations in cutaneous melanoma 1.55
Epigenomic profiling reveals the key function of histone H3K9 methylation during tumor transformation process 1.55
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation [RNA-Seq] 1.55
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation 1.55
Cellular response to hepatitis E virus (HEV) infection 1.55
Induction of human SST and PV neurons by expressing a single transcription factor LHX6 1.55
Overexpression of NFIB and YBX1 in MCF-7 cells 1.53
Effect of mitochondria deficiency on senescence-associated gene expression 1.53
Ribosome profiling of TGFb-treated cells indicates reduced leucine availability 1.53
Expression analysis of PC3 cells treated with scramble AON or AON directed against MBNL1 1.51
ZNF131 suppresses centrosome fragmentation in Glioblastoma stem-like cells through regulation of HAUS5 1.51
Acetylation of spliceosome protein PHF5A modulates stress responses and colorectal carcinogenesis through alternative splicing mediated upregulation of KDM3A 1.5
SF3B1 Degron knockdown RNA-seq 1.5
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma [RNA-seq] 1.49
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma 1.49
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [HCC1599_RNA-seq] 1.49
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression 1.48
Integrative analysis identifies targetable CREB1/FoxA1 transcriptional co-regulation as a predictor of prostate cancer recurrence 1.48
Expression Analysis of dic(1;7)(q10;p10) in Myelodysplastic Syndromes (MDS) compared to control cohort and therapy-related Myeloid Neoplasms (t-MN) 1.47
A Distinct Epigenetic Program Underlies the 1;7 Translocation in Myelodysplastic Syndromes (MDS) 1.47
LEDGF and HDGF2, histone H3K36 methyl-binding proteins that assist RNA polymerase II transcription through nucleosomes 1.47
Gene expression alterations associated with acquired-resistance to the CDK4/6 inhibitor palbociclib [Palbociclib resistance_RNASeq] 1.47
RNA-seq and m6A-seq of AML cells with FTO knockdown or inhibition 1.46
Effects of Belinostat and Dexamethasone treatment of A549 gene expression 1.46
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [HCT RNA-Seq] 1.46
RNA-seq after siRNA targeting DDX24 applied to iHUVECs cell lines 1.46
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (LNCaP RNA-seq) 1.45
Exploring the gene expression profile upon FXR1 knockdown in H358 cells using RNA-seq 1.45
Function of HNRNPC in breast cancer cells by controlling the dsRNA-induced interferon response 1.45
Gene expression regulated by CSA and CSB in neuroblastoma cell line 1.45
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer [RNA-seq] 1.44
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer 1.44
Small molecule targets TMED9, promotes lysosomal degradation to reverse proteinopathy 1.44
Expression profiles of long non-coding RNAs located in autoimmune disease-associated regions reveal immune cell type specificity 1.44
Over expression of Receptor Activity Modifying Protein 2 in HEK293T cells 1.44
Targets of CDK12 on ZR-75-30 breast cancer cells (RNA-seq) 1.44
Transcriptomics analysis of gene expression in normal and METTL3 or WTAP deficient Human HeLa cells 1.43
Functional Importance of eRNAs for Estrogen-dependent Gene Transcriptional Activation 1.43
RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 1.42
RNA-seq Profiles in RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 1.42
Luminal lncRNAs Regulation by ERα-controlled Enhancers in a Ligand-independent Manner in Breast Cancer Cells 1.41
Transcriptional changes in pancreatic cancer cells associated with gemcitabine resistance 1.4
Messenger RNA expression after silencing or inhibition of MEN1in MCF-7 breast cancer cells 1.39
RNA-seq analysis of HT-29, MCF10A, and MDA-MB-436 cells 1.39
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells 1.39
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells (RNA-Seq) 1.39
Gene expression profiles in HMC3 cells after exposure to ketamine or its active metabolites: 2R6R-HNK and 2S6S-HNK 1.38
Function and hormonal regulation of GATA3 in human first trimester placentation 1.38
RNA profiling Analysis of the Serum Exosomes Derived from Active and Latent M.tuberculosis infectious Patients 1.37
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on PANC1 cells treated with CoCl2) 1.37
Integrated multi-omics approach reveals a role of ALDH1A1 in lipid metabolism in human colon cancer cells 1.35
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer 1.35
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer [RNA-Seq] 1.35
RNA transcriptome analysis during HSV-1 infection 1.34
LncRNA NONHSAT113026 represses renal cell carcinoma tumorigenesis through interacting with NF-κB/p50 and SLUG 1.34
Multiple mechanisms disrupt let-7 miRNA biogenesis and function in neuroblastoma 1.33
Inhibition of SF3B1 by molecules targeting the spliceosome in Rh18 cells 1.33
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer [RNA-Seq] 1.32
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer 1.32
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors 1.32
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 1.32
RNA-seq of exosomes identifies lncRNA profiles that distinguish early-stage esophageal squamous cell carcinoma (ESCC) from non-malignant esophagitis 1.32
RNA splicing alteration on glioblastoma and normal neural stem cells 1.31
Expression data from human perivascular stem cell-derived extracellular vesicles (PSC-EVs) and PSCs 1.29
SNHG12 knockdown in Human Umbilical Vein Cells under ROS conditions. 1.29
Transcriptome wide identification of retained introns upon depletion of the splicing factors SNW1 or PRPF8 1.29
Interferon receptor signaling pathways regulating PD-L1 and PD-L2 expression 1.29
RNA-seq in transgenic cells 1.28
MALT1 Inhibition Is Efficacious in Both Naïve and Ibrutinib-Resistant Chronic Lymphocytic Leukemia. 1.27
The MEF2B Regulatory Network 1.27
The MEF2B Regulatory Network - RNA-seq data 1.27
Epigenetic reprogramming at estrogen-receptor binding sites alters the 3D chromatin landscape in endocrine resistant breast cancer [RNA-seq] 1.27
Epigenetic reprogramming at estrogen-receptor binding sites alters 3D chromatin landscape in endocrine resistant breast cancer 1.27
Coordinated control of senescence by lncRNA UCA1 and a novel CAPERα/TBX3 co-repressor 1.26
SRSF1 role in cellular gene expression and splicing 1.26
GREB1 amplifies androgen receptor output in prostate cancer and contributes to antiandrogen resistance 1.25
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines 1.25
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines [RNA-Seq] 1.25
ZNF804A transcriptome networks in differentiating human neurons derived from induced pluripotent stem cells 1.25
Three-dimensional Oxabicycloheptene sulfonate targets the homologous recombination and repair programs through estrogen receptor α antagonism 1.25
Whole transcriptome splicing analysis in isogenic lung epithelial and adenocarcinoma cell lines with or without a recurrent splicing factor mutation, U2AF1 (S34F) 1.24
Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of binding sites in a cell type-specific manner 1.24
Mutant KRAS/BRAF Reprograms the Enhancer Landscape via GATA1 to Drive Chemoresistance 1.22
UBC9 knockdown in bladder cancer T24 cell lines 1.22
R430: A potent inbibitor of DNA and RNA viruses 1.21
4sUDRB-seq: measuring transcription elongation and initiation genomewide 1.21
RNAseq of HEK293 cells after Chtop knockdown 1.21
Co-transcriptional loading of RNA export factors shapes the human transcriptome 1.21
Gene expression in GBM with Cav3.2 inhibition 1.2
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation 1.2
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation [RNA-Seq] 1.2
Transcriptome sequencing of human coronary artery smooth muscle cell under treatment of nitrated fatty acid 1.2
The E3 ubiquitin ligase HectD1 suppresses EMT and metastasis by targeting the +TIP protein ACF7 for degradation 1.19
Identification of a core p53 transcriptional program with highly fractionated tumor suppressive activity 1.19
GRO-seq from HCT116, MCF7 and SJSA cell lines treated with DMSO and Nutlin 1.19
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 1.19
MYT1 attenuates neuroblastoma cell differentiation by inhibiting retinoic acid signaling pathway 1.18
Transcriptome analysis of AGS cells infected with Helicobacter pylori P12 1.18
Next Generation Sequencing Facilitates Comparisons of Control and Schizophrenia-Patient derived hiPSC-derived neurons 1.18
Glioblastoma stem cells infected by ZIKA virus 1.18
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype 1.18
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype [RNA-Seq] 1.18
The effect of insulin on mRNA transcription of human pluripotent stem cells 1.17
Next Generation Sequencing Facilitates Quantitative Analysis of transcriptomes of human cord blood CD34+ cells treated with HDAC5 inhibitor 1.17
Human SETMAR is a DNA sequence-specific histone-methylase with a broad effect on the transcriptome 1.15
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival [RNA-Seq] 1.15
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival 1.15
UMI-count modeling and differential expression analysis for single-cell RNA sequencing 1.14
Homolog-selective degradation as a strategy to probe the function of CDK6 in AML 1.14
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells (RNA-seq) 1.13
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells 1.13
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-Seq KO] 1.13
Human iPSC-based Modeling of Late-Onset Disease using Progerin-induced Aging 1.13
High-throughput sequencing of pluripotent cells 1.13
Differentiation enhances Zika virus infection in neuronal brain cells 1.13
RNA expression profiling of human mPB or CB-derived CD34+ cells treated with UM171 at different doses 1.12
Transcriptome splicing analysis in K562 cells expressing rare and private spliceosomal mutations 1.12
Transciptome profiling of NoDice and RNaseIII null cells prior to and after polyIC treatment 1.11
Effect of CRISPR-Cas9 mediated knock-out of integrin alpha2 on the transcriptome of DU145 prostate cancer cell grown as a spheroid culture 1.11
RNA-seq analysis of uveal melanoma cells treated with FR900359 1.11
Fisetin induces autophagy in pancreatic cancer cells via endoplasmic reticulum stress- and mitochondrial stress-dependent pathways 1.1
PT2385 HIF2A inhibitor treatment of patient derived orthotopic xenograft neuroblastoma cells in the presence or absence of hypoxia 1.1
Epigenetic Inactivation of Cysteine Dioxygenase Type 1 Contributes to ROS-dependent Progression of Colorectal Cancer 1.09
Transcriptomic profiling of human HAP1 cells before and after nutrient deprivation 1.09
Human HAP1 cells before and after nutrient deprivation 1.09
Gene expression profiling by RNA-seq of SW480 TGM2 knockdown cells 1.08
Lysine benzoylation is a novel histone mark 1.07
Lysine benzoylation is a novel histone mark [RNA-seq] 1.07
TWIST1-induced microRNA-424 drives an intermediate epithelial-to-mesenchymal transition that opposes metastasis 1.07
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 1.07
Human TFIIH kinase CDK7 regulates transcription-associated epigenetic modification 1.07
Transcriptome-wide profiling of poly(A)-tail length, translation efficiency and mRNA stability using TED-seq, mRNA-seq, Ribo-seq and PRO-seq in ER stress conditions 1.06
Functional Haploid Human Oocytes Generated from Polar Body Genomes (RNA-Seq) 1.06
Functional Haploid Human Oocytes Generated from Polar Body Genomes 1.06
RNA-Seq of CD4+ T cells treated with AS1842856 or DMSO 1.05
Neuronal Development And The Onset Of Electrical Activity In The Human Enteric Nervous System 1.04
Transcriptome Profiling of Influenza A Virus-infected Lung Epithelial (A549) Cells with Lariciresinol-4-β-D-glucopyranoside Treatment 1.04
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 1.04
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 1.04
MYCi361 regulates MYC target genes 1.03
RNA-sequencing analysis for gene expression profiles affected by CASC9 knockdown 1.03
Bromodomain and extraterminal proteins foster the core transcriptional regulatory programs and confer vulnerability in liposarcoma (RNA-Seq) 1.02
Bromodomain and extraterminal proteins foster the core transcriptional regulatory programs and confer vulnerability in liposarcoma 1.02
ELAVL2-regulated transcriptional networks in human neurons link atlernative splicing, autism and human neocortical evolution 1.01
RNA-Guided Human Gene Activation by Cas9/CRISPR-Based Engineered Transcription Factors 1.01
Effect of venetoclax, tedizolid, and combination treatment on gene expression in a venetoclax-resistant AML cell line 1.0
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) [RNA-seq] 1.0
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) 1.0
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer 1.0
Identifying the molecular mode of action of itraconazole in colorectal cancer 1.0
HEK293 Heat-shock experiment 0.99
Bioinformatics analysis of transcriptome related to blood stasis syndrome in diabetes mellitus patients 0.97
Capturing the Interactome of Newly Transcribed RNA 0.97
Capturing the Interactome of Newly Transcribed RNA (RICK) 0.97
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer [RNA-Seq] 0.97
A damaged genome's transcriptional landscape through multilayered expression profiling around in situ-mapped DNA double-strand breaks 0.97
ChIP-seq and RNA-seq analysis of KMT2D-silenced metastatic melanoma cells 0.96
RNAseq to determine whether bidirectional transcription occurs over transposable elements following depletion of SETDB1 in THP-1 AML Cells 0.96
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 0.94
Single-cell RNA-seq reveals differentiation of bona fide human pDCs and cDC1s in cultures of cord blood CD34+ progenitors, and a newly identified terminal differentiation step of cDC1s 0.93
Transcriptional study of ARN8 cells treated with novel DHODH inhibitors 0.92
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 0.91
Next generation sequencing of human hepatic stellate cell line, LX-2 treated with recombinant human TGF-β1, with DMSO or ML290 (5 µM) for 72h. 0.9
CD73 knockdown effect in pancreatic cancer cell lines 0.9
RNA sequencing of CACO-2 cells incubated with Bifidobacteria breve grown on human milk oligosaccharides. 0.9
Tumor hypoxia causes DNA hypermethylation by reducing TET activity (RNA-Seq) 0.89
Tumor hypoxia causes DNA hypermethylation by reducing TET activity 0.89
miR-450a acts as a tumor suppressor in ovarian cancer by readjusting energy metabolism 0.89
High-Throughput Kinetic Analysis of Fractional Killing 0.88
Expression profile of GIST48 cells with siETV1 or siFOXF1 knockdown 0.88
FOXF1 defines the core-regulatory circuitry in gastrointestinal stromal tumor (GIST) 0.88
Oncolytic reactivation of KSHV as a therapeutic approach for primary effusion lymphoma: RNA-sequencing of PEL cell lines during KSHV reactivation 0.88
Genome-wide Dose-dependent Inhibition of Histone Deacetylases Reveals Their Roles in Enhancer Remodeling and Suppression of Oncogenic Super-enhancers 0.88
snRNAs as regulators of alternative splicing 0.86
IRF1 regulates IFN dependent and independent gene expression 0.85
Transcription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial transition in human cancer 0.85
RNA Seq data: A375, A375R, A375DR vorinostat treated, and biopy samples from patients pre- and post- treated with Vorinostat 0.85
An acquired vulnerability of drug resistant melanoma with therapeutic potential 0.85
Microenvironmental-derived Regulation of HIF-Signaling Drives Transcriptional Heterogeneity in Glioblastoma Multiforme 0.85
Discovery and verification of liver cancer marker genes and variable scission based on second-generation sequencing data analysis 0.82
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation 0.81
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation (RNA-seq data) 0.81
Osmostress induced changes of chromatin architecture and transcription in mammalian cells [RNA-Seq, HiC] 0.79
Osmostress induced changes of chromatin architecture and transcription in mammalian cells 0.79
ROR-γ drives androgen-receptor expression and represents a therapeutic target in castration-resistant prostate cancer 0.79
RNA-seq of young and quiescent MRC-5 human fibroblasts 0.79
Identification of global XBP1s target gene expression in human prostate cancer cells 0.79
Transcriptome of U251 cells overexpression complement component 7 0.78
Effect of PRDM11 depletion in U2932 cells 0.77
Genome-wide effect of inhibition of glutamine transporter ASCT2 in PC-3 cells by BenSer or GPNA 0.77
Transcriptome analysis of human embryonic stem cells (hESCs) upon siRNA-mediated knockdown of hESC-essential genes 0.76
Proteotranscriptomic profiling of potential E6AP targets in prostate cancer cells 0.76
Total RNA-seq in ALL-SIL upon TLX1 knockdown 0.76
Patient-derived xenograft platform for metastatic melanoma 0.75
RNA Seq of HMVEC under hypoxia 0.75
Endothelial-AGO1-knockout (EC-AGO1-KO) mice and wild-type (WT) littermates 0.75
Meta-organization of Translation Centers Revealed by Proximity Mapping of Endoplasmic Reticulum Ribosome Interactors 0.75
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and PVT1 Knockdown by CRISPRi in MDA-MB-231 human breast cancer cell line 0.74
Promoter of lncRNA gene *PVT1* is a tumor suppressor DNA element 0.74
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network with PRC2 [RNA-seq] 0.74
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network 0.74
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B-cell Responses to Influenza Hemagglutinin 0.74
RNA sequencing of mechanically strained NHEKs and control NHEKs 0.73
Intrinsic histone acetyltransferase activity of BRD4 is responsible for nucleosome eviction and transcriptional activation 0.71
PRDM1 inhibits proliferation of human colon cancer organoids 0.71
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations 0.7
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations [RNA-Seq] 0.7
TRIM24 is an oncogenic transcriptional co-activator of STAT3 in glioblastoma 0.69
LncPRESS1 is a p53-regulated lncRNA that safeguards pluripotency by disrupting SIRT6 mediated de-acetylation of histone H3K56 0.69
Transcriptomic analysis of senescent cells upon PTBP1 knockdown. 0.68
Genome-wide modelling of transcription kinetics reveals patterns of RNA processing delays 0.67
RNA-seq of three Ewing sarcoma cell lines (A673, SK-N-MC, RDES), transfected with either siControl or siMYBL2. 0.67
Cooperation of dominant oncogenes with regulatory variants shapes clinical outcomes in pediatric cancer 0.67
RNA-seq data of small cell carcinoma of the bladder (SCCB) /urothelial carcinoma (Non-SCCB) clinical samples, and bladder-PARCB cell lines 0.67
RNASEQ Analysis of sh-TRC and sh-MIR100HG in the triplex negative breast cancer 0.67
Simultaneous detection and relative quantification of coding and non-coding RNA using a single sequencing reaction 0.67
Effector and regulatory T cells roll at high shear stress by inducible tether and sling formation 0.66
Analyses of a panel of transcripts and construction of RNA networks in hepatocellular carcinoma 0.66
N6-methyladenosine (m6A) profiling of EndoC-bH1 cell line and RNA seq of Mettl14 knockout mice beta cell 0.66
Conservative alteration of chromosomal expression pattern across human solid tumor types 0.65
Fixed tissue ChIP-Seq (FiT-Seq) of archived clinical samples reveals chromatin dynamics and tumor-specific enhancer profiles 0.64
Inhibition of ERG Activity in Patient Derived Prostate Cancer Xenografts using the Small Molecule Inhibitor YK-4-279 0.64
Lipid catabolism inhibition sensitizes prostate cancer cells to antiandrogen blockade 0.63
Massive parallel sequencing uncovers actionable FGFR2-PPHLN1 fusion and ARAF mutations in intrahepatic cholangiocarcinoma 0.63
Distinct roles of cohesin-SA1 and cohesin-SA2 in 3D chromosome organization  0.62
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and SMAD4 Y95 Mutation Transcriptomes 0.61
The human blood-nerve barrier transcriptome 0.61
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (22RV1 RNA-seq) 0.61
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability 0.61
The Polycomb Repressor Complex 1 Drives Double-Negative Prostate Cancer Metastasis by Coordinating Stemness and Immune Suppression 0.61
Transcriptome analysis of BAP1 knockout and restoration 0.59
Expression profiles of restoration of BAP1 in a BAP1 deficient cell line 0.59
A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors 0.58
Insights into snoRNA biogenesis and processing from PAR-CLIP of snoRNA core proteins and small RNA sequencing 0.58
Functional role of CPPED1 in trophoblasts. 0.58
RNA-Seq analysis of human colorectal cancer with liver metastasis 0.56
RNA-seq in HT-29 colorectal cancer cells after F. nucleatum treatment 0.54
Gene expression analysis of C4-2 cells treated with ACLY inhibitor and Enzalutamide 0.54
RNA-Seq with DHT induction and/or GSK treatment at 24, 48 hrs and 2 weeks 0.54
FOXA1 Chromatin Binding is Regulated by LSD1-Mediated Demethylation 0.54
Impact of ETV7 activity on interferon-stimulated gene expression in 293T cells treated with interferon alpha 0.52
ETV7 and interferon response 0.52
FUS KO mRNA sequencing and anti-FUS RNA immunoprecipitation sequencing 0.51
The CDK7 Inhibitor THZ1 Alters RNA Polymerase Dynamics at the 5’ and 3’ Ends of Genes 0.51
Entrectinib Resistance in a Neuroblastoma Xenograft Model 0.51
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 0.5
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 0.5
c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas 0.5
c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas [RNA-Seq] 0.5
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells 0.49
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells [RNA-Seq] 0.49
Suppression of the FOXM1 transcriptional program via novel small molecule inhibition 0.48
Characterisation of HIF-dependent alternative isoforms in pancreatic cancer 0.48
RNAseq in Alzheimer's Disease patients 0.47
Human ES Cell-derived Hepatoblasts are an Optimal Lineage Stage for HCV Infection 0.47
RNA-sequencing of epicardial adipose tissue of patients with atrial fibrillation 0.46
SMUG1 promotes telomere maintenance through telomerase RNA end-processing 0.46
BASP1 modifies the Tamoxifen response 0.45
Investigate A2M treatment on human prostate cancer and mouse liver 0.45
Investigate A2M treatment on human prostate cancer xenograft in mice 0.45
Ribosomal protein RPL26 is the principal target of UFMylation 0.45
Isolation and sequencing of AGO-bound RNAs reveals characteristics of stem-loop processing in vivo 0.45
Functional significance of the HIV-1 Tat signature amino acid residues 0.43
CRISPR-Cas9 combinatorial KO of epigenetic regulators in human ovarian cancer cells 0.42
Transcriptomics profiling of Alzheimer’s disease reveal novel molecular targets 0.41
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle 0.4
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle [RNA-seq] 0.4
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L 0.4
RNA-Seq of SLNCR1 over-expression in the melanoma cell line A375 0.39
Transcriptome Analysis Reveals Distinct Responses to Physiologic versus Toxic Manganese Exposure in Human Neuroblastoma Cells 0.39
Widespread Transcription beyond mRNA 3’ Ends Yields Abundant Regulatory RNAs 0.39
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 0.38
mRNA sequencing of oropharyngeal cancer cell lines 0.37
Transcriptional dependencies in diffuse intrinsic pontine glioma 0.37
Functional characterization of human T cell hyporesponsiveness induced by CTLA4-Ig 0.37
Transcriptional Profiling of Werner Syndrome (WS) iPSC-derived MSC and the isogenic gene-edited controls 0.36
A SRp55-regulated alternative splicing network controls pancreatic beta cell survival and function 0.36
Gene expression in mature and immature human ES-derived beta cells, and sorted beta-cells from adult islets 0.35
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 0.35
Global transcriptome analysis in the MYCN-amplified neuroblastoma cell line IMR5-75 upon inducible MYCN-knockdown 0.35
Chemical Modulation of Glycolysis Regulates the KEAP1-NRF2 Pathway Through a Metabolite-Induced Posttranslational Modification 0.34
GLIS3 Transcriptionally Activates WNT Genes to Promote Differentiation of Human Embryonic Stem Cells to Posterior Neural Progenitors 0.31
Targeting Chromatin Regulators Inhibits Leukemogenic Gene Expression in NPM1 Mutant Leukemia 0.31
Azithromycin induces epidermal differentiation and multivesicular bodies in airway epithelia 0.31
Antiviral and anti-inflammatory properties of novel anti-HIV candidate ABX464 promotes specifics RNA splicing while preserving cellular RNA integrity. 0.31
Gene expression from AsPC-1 cells treated with PTC596 and DMSO 0.3
Transcriptome-wide analysis to determine miR-200a targets in melanoma cell lines 0.3
Role of FGFR1 in neuronal devlopment 0.28
Recurrent alterations of TNFAIP3 (A20) in T-cell large granular lymphocytic leukemia 0.27
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: Comparison of gene expression profiling approaches 0.27
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: Comparison of gene expression profiling approaches [RNA-Seq] 0.27
A cell cycle-based functional screen to identify lncRNA-based cancer biomarkers 0.26
Differential YAP expression in glioma cells induces cell competition and promotes tumorigenesis 0.26
Generation of low passage high grade serous ovarian cancer cell lines from primary tumors 0.26
The role of m6A/m-RNA methylation in stress response regulation 0.25
m6A/m-Seq of human B-lymphocyte cell lines from healthy controls and major depressive disorder patients 0.25
Disease modelling of core pre-mRNA splicing factor haploinsufficiency 0.25
Illumina HiSeq Sequencing on Breast cancer PDX samples 0.24
Human optic chiasm from healthy controls and multiple sclerosis patients 0.24
Multiple sclerosis and EAE 0.24
Network-based, cross-cohort discovery of transcriptional mechanisms presiding over maintenance of high-risk neuroblastoma subtype state 0.23
RNA-seq of shEZH2 cells 0.23
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 1) 0.22
Genome-wide Gene Expression Profiling in DLBCL Cell Lines Treated with CUDC-907 0.22
Comparison of expression profiles of APP-depleted prostate cancer cells (LNCaP) 0.22
Genome-Wide Specificity of DNA-Binding, Gene Regulation, and Chromatin Remodeling by TALE- and CRISPR/Cas9-Based Transcription Factors 0.22
Combinatorial Regulation Mediated by Biochemically Distinct Forms of SWI/SNF [RNA-Seq] 0.21
Genome-Wide Transcriptional Regulation Mediated By Biochemically Distinct Forms of SWI/SNF 0.21
Epigenomic conservation of transposable element silencing 0.21
Epigenomic conservation of transposable element silencing [RNA-seq] 0.21
Gene expression analysis upon mtDNA depletion [RNA-seq] 0.2
Gene expression analysis upon mtDNA depletion 0.2
Activin/Smad2-induced H3K27me3 reduction is crucial to initiate mesendoderm differentiation of ES Cells 0.2
RNA-seq of PC3 prostate cancer cell line xenografts in mice administered the ghrelin receptor antagonist [D-Lys3]-GHRP-6 or PBS for two weeks 0.19
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures 0.19
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures [RNA-Seq] 0.19
RNA sequencing of prostate cancers reveal insights on the prognostic significance of visibility on multi-parametric MRI 0.19
DLX3-dependent p53 signaling network controls keratinocyte cell cycle and squamous tumor growth 0.17
DLX3 alters transcriptomic profile of adhesion, cell cycle, and cell death in Squamous Cell Carcinoma Cells 0.17
Transcriptome of Primitive Human Hematopoietic Cells: A New Resource to Find hHSC-Specific Genes 0.17
Gene expression in TAL1-driven T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 0.16
T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 0.16
Gene expression profiling of patient's DCIS-IDC tandem lesions by RNA sequencing analysis 0.16
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells 0.16
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML [RNA-Seq human] 0.16
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML 0.16
Networks of cultured iPSC-derived neurons reveal the human synaptic activity-regulated adaptive gene program 0.14
Genome-wide search for differentially expressed RNAs responsible for the effects induced by Ebola virus replication and transcription 0.14
Aberrant expression profile of lncRNA and mRNA in dilated cardiomyopathy by RNA-sequence 0.13
Molecular characterization of BRSK2 and BRSK1 kinases as negative regulators of the NRF2 transcription factor 0.13
RNA sequencing of human pancreatic cancer cell lines 0.13
Genome wide association study of bone size yields eleven loci that also affect height, bone density, osteoarthritis and fractures 0.13
Effect of nuclear IL-33 on gene expression 0.12
RNA-seq of SOX5 overexpressing primary human neuronal progenitors 0.12
Global transcriptomic analyses of bronchial epithelial cells exposed to 5 ng/mL TGF-β1 and 10 nM Estrogen individually and in combination 0.12
KANK1 inhibits cell growth by inducing apoptosis though regulating CXXC5 in human malignant peripheral nerve sheath tumors 0.11
Enhancer activation during EGF response 0.11
Myc activation coordinates gene transcription and protein translation responses 0.1
Rational targeting of cooperating layers of the epigenome yields enhanced therapeutic efficacy against AML 0.1
RNA Missplicing in Fuchs Endothelial Corneal Dystrophy 0.1
Downregulation of DDX5/DDX17 and REST 0.1
RNA-sequencing of the brain transcriptome implicates dysregulation of neuroplasticity, circadian rhythms, and GTPase binding in bipolar disorder 0.09
BRD9 defines a novel SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors [RNA-seq 2] 0.08
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma 0.08
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma (RNA-Seq) 0.08
Carcinoma-astrocyte gap junctions promote brain metastasis by cytosolic dsDNA response transfer 0.07
Compensatory Csf2-driven macrophage activation blunts long-term efficacy of therapeutic Csf1r inhibition in breast-to-brain metastasis 0.07
Inhibition of H3K4 demethylation induces autophagy in cancer cell lines 0.07
RNA-Seq of the corpus callosum from 12 individuals 0.06
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 [RNA-seq] 0.06
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 0.06
Analysis of transcriptomes of healthy donor and CD46 deficient CD8 T cells 0.05
Transcriptome analysis of CD8+ T cells from healthy controls and patients wth CD46 deficiency 0.05
ZEB1 insufficiency causes corneal endothelial cell state transition and altered cellular processing 0.05
mRNA Sequencing of Human PromoCells Using Random Primed mRNA-Sequencing Technique 0.04
The RNA-binding protein RBM47 suppresses metastatic breast cancer progression 0.04
RNA sequencing of bone marrow CD34+ cells from myelodysplastic syndrome patients with and without SF3B1 mutation and from healthy controls 0.04
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of HSCe) 0.03
SAMHD1 is recurrently mutated in T-cell prolymphocytic leukemia [RNA-seq] 0.03
Compare of gene expression between p16INK4A positive and negative regions of colon cancer from five patients 0.02
RB tumor suppressor promotes cancer immunity through downregulating PD-L1 expression 0.02
Nickel exposure induces persistent mesenchymal phenotype in human lung epithelial cells through epigenetic activation of ZEB1 0.02
Expression changes in MAPKi resistant M229 melanoma lines co-cultured with PD-1 overexpressing HEK293T cells [CellLine.FPKM.batch5] 0.0
Functional genomic analysis of the haploinsufficient tumor suppressor, CUX1 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation